Saturday, June 13

Browsing: PTENDeficient

Survivors

Capivasertib Combo Earns FDA Approval in PTEN-Deficient Metastatic HSPC

By NewsCancerJune 12, 20260

The FDA has approved the combination of capivasertib (Truqap) plus abiraterone (Zytiga) and predinsone as a treatment for patients with…

Diagnosis

By NewsCancerApril 30, 20260

The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 7 to 1 in favor of the supplemental new drug application (sNDA)…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.